Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
WuXi NextCODE
Asia
WuXi NextCODE, remdesivir generics and more—FiercePharmaAsia
WuXi NextCODE restructures and changes its name. Cipla and Hetero Labs launch remdesivir copies in India. Sinopharm preps COVID shot's phase 3 trial.
Angus Liu
Jun 26, 2020 8:55am
FiercePharmaAsia—CFDA, Celltrion, WuXi NextCODE
Mar 16, 2018 10:25am
FiercePharmaAsia—Takeda, Shanghai Pharma, WuXi NextCODE
Jan 26, 2018 9:37am
FiercePharmaAsia—JSR, Orchid, Tessa and more
Dec 21, 2017 8:25am
FiercePharmaAsia—WuXi NextCODE, Celltrion, Biocon
Sep 15, 2017 9:54am
FiercePharmaAsia—Takeda, WuXi NextCODE, Dr. Reddy’s
May 5, 2017 9:51am
